clofutriben

Phase 1Small molecule

SSparrow Pharmaceuticals

clofutriben is one of 2 small molecule programs targeting Impaired Renal Function. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Impaired Renal FunctionRecruiting

Impaired Renal FunctionPhase 1

Recruiting

Competition

Competitive Landscape

1 competitor in Impaired Renal Function

#DrugCompanyPhaseTrials

SAP-001

SShanton Pharma Co., Ltd.

Phase 2

1 2

clofutriben

SSparrow Pharmaceuticals

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2028

Phase 2Recruiting

Type 2 Diabetes

NCT07296484

Clinical

Trials by Indication[1]

Impaired Renal Function1 trial

Clofutriben Pharmacokinetics in Patients With Impaired Renal Function

Recruiting·SSparrow Pharmaceuticals·Phase 1·NCT07227922·16 enrolled

Type 2 Diabetes1 trial

Clofutriben And Placebo Phase 2 Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Recruiting·SSparrow Pharmaceuticals·Phase 2·NCT07296484·1,500 enrolled

Unspecified1 trial

Pharmacokinetic Interaction Trial of Clofutriben With Midazolam and Prednisolone

Completed·SSparrow Pharmaceuticals·Phase 1·NCT07226635·16 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for clofutriben. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — clofutriben compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for clofutriben. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sparrow Pharmaceuticals company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: SSparrow Pharmaceuticals

clofutriben

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q2 2028

Trials by Indication[1]

Impaired Renal Function1 trial

Type 2 Diabetes1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News